An employee shows drugs produced at Lefortovsky branch of the Moscow Endocrine Plant, in Moscow, Russia.22.03.2023#8395863
An employee shows drugs produced at Lefortovsky branch of the Moscow Endocrine Plant, in Moscow, Russia.22.03.2023#8395864
A view shows the production site of the pharmaceutical company Renewal, in Novosibirsk, Russia.18.04.2022#8169142
An employee is pictured during a workflow at the production site of the pharmaceutical company Renewal, in Novosibirsk, Russia.18.04.2022#8169146
Packs with L-thyroxine tablets are seen displayed on a table at the production site of the pharmaceutical company Renewal, in Novosibirsk, Russia.18.04.2022#8169132
Packs with L-thyroxine tablets are seen displayed on a table at the production site of the pharmaceutical company Renewal, in Novosibirsk, Russia.18.04.2022#8169131
A view shows the production site of the pharmaceutical company Renewal, in Novosibirsk, Russia.18.04.2022#8169143
A view shows the production site of the pharmaceutical company Renewal, in Novosibirsk, Russia.18.04.2022#8169148
An employee is pictured during a workflow at the production site of the pharmaceutical company Renewal, in Novosibirsk, Russia.18.04.2022#8169150
An employee is pictured during a workflow at the production site of the pharmaceutical company Renewal, in Novosibirsk, Russia.18.04.2022#8169133
A view shows the production site of the pharmaceutical company Renewal, in Novosibirsk, Russia.18.04.2022#8169145
An employee is pictured during a workflow at the production site of the pharmaceutical company Renewal, in Novosibirsk, Russia.18.04.2022#8169149
An employee is pictured during a workflow at the production site of the pharmaceutical company Renewal, in Novosibirsk, Russia.18.04.2022#8169151
An employee is pictured during a workflow at the production site of the pharmaceutical company Renewal, in Novosibirsk, Russia.18.04.2022#8169152
A view shows the production site of the pharmaceutical company Renewal, in Novosibirsk, Russia.18.04.2022#8169135
A view shows the production site of the pharmaceutical company Renewal, in Novosibirsk, Russia.18.04.2022#8169163
An employee is pictured during a workflow at the production site of the pharmaceutical company Renewal, in Novosibirsk, Russia.18.04.2022#8169137
An employee is pictured during a workflow at the production site of the pharmaceutical company Renewal, in Novosibirsk, Russia.18.04.2022#8169162
An employee is pictured during a workflow at the production site of the pharmaceutical company Renewal, in Novosibirsk, Russia.18.04.2022#8169136
A view shows the production site of the pharmaceutical company Renewal, in Novosibirsk, Russia.18.04.2022#8169157
A view shows the production site of the pharmaceutical company Renewal, in Novosibirsk, Russia.18.04.2022#8169153
A view shows the production site of the pharmaceutical company Renewal, in Novosibirsk, Russia.18.04.2022#8169161
A view shows the production site of the pharmaceutical company Renewal, in Novosibirsk, Russia.18.04.2022#8169144
An employee is pictured during a workflow at the production site of the pharmaceutical company Renewal, in Novosibirsk, Russia.18.04.2022#8169156
A view shows the production site of the pharmaceutical company Renewal, in Novosibirsk, Russia.18.04.2022#8169154
A view shows the production site of the pharmaceutical company Renewal, in Novosibirsk, Russia.18.04.2022#8169155
A view shows the production site of the pharmaceutical company Renewal, in Novosibirsk, Russia.18.04.2022#8169160
An employee is pictured during a workflow at the production site of the pharmaceutical company Renewal, in Novosibirsk, Russia.18.04.2022#8169141
An employee is pictured during a workflow at the production site of the pharmaceutical company Renewal, in Novosibirsk, Russia.18.04.2022#8169159
An employee is pictured during a workflow at the production site of the pharmaceutical company Renewal, in Novosibirsk, Russia.18.04.2022#8169140
An employee is pictured during a workflow at the production site of the pharmaceutical company Renewal, in Novosibirsk, Russia.18.04.2022#8169158
An employee is pictured during a workflow at the production site of the pharmaceutical company Renewal, in Novosibirsk, Russia.18.04.2022#8169138
Tablets are pictured during a demonstration of the production process of antiviral drug Favipiravir at the enterprise of ChemRar Group in Khimki, outside Moscow, Russia. Russia is set to test Favipiravir, an off-patent drug originally owned by Japanese drug maker Fujifilm Toyama Chemical, as a treatment for coronavirus patients as it holds potential against RNA viruses, one of which is Covid-19.30.04.2020#6232015
An employee walks at a pharmaceutical factory warehouse, in Biysk, Altai Krai region, Russia.12.07.2019#5944384
An employee walks at a pharmaceutical factory, in Biysk, Altai Krai region, Russia.12.07.2019#5944381
An employee works at a pharmaceutical factory, in Biysk, Altai Krai region, Russia.12.07.2019#5944380
Pills are pictured at a pharmaceutical factory, in Biysk, Altai Krai region, Russia.12.07.2019#5944379
An employee holds capsules produced at a pharmaceutical factory, in Biysk, Altai Krai region, Russia.12.07.2019#5944378
An employee works at a pharmaceutical factory, in Biysk, Altai Krai region, Russia.12.07.2019#5944377
An employee works at a pharmaceutical factory, in Biysk, Altai Krai region, Russia.12.07.2019#5944409
An employee works at a pharmaceutical factory, in Biysk, Altai Krai region, Russia.12.07.2019#5944372
A worker in the quality testing lab at the Stirolbiopharm pharmaceutical plant, Donetsk Region.30.08.2018#5621069
The quality testing lab at the Stirolbiopharm pharmaceutical plant, Donetsk Region.30.08.2018#5621082
A technician in the quality testing lab at the Stirolbiopharm pharmaceutical plant, Donetsk Region.30.08.2018#5621099
A worker in the packaging shop at the Stirolbiopharm pharmaceutical plant, Donetsk Region.30.08.2018#5621096
A worker in the packaging shop at the Stirolbiopharm pharmaceutical plant, Donetsk Region.30.08.2018#5621097
A worker in the packaging shop at the Stirolbiopharm pharmaceutical plant, Donetsk Region.30.08.2018#5621102
A worker in the granulation shop at the Stirolbiopharm pharmaceutical plant, Donetsk Region.30.08.2018#5621136
A worker in the granulation shop at the Stirolbiopharm pharmaceutical plant, Donetsk Region.30.08.2018#5621058
A worker in the granulation shop at the Stirolbiopharm pharmaceutical plant, Donetsk Region.30.08.2018#5621104
Maxim Lebedev, director of the Stirolbiopharm pharmaceutical plant, Donetsk Region.30.08.2018#5621115
Pills confiscated by the Russian Federal Security Service during the arrest of the group involved in organizing illegal cross-border drugs and psychotropic substances trafficking channels on an especially large scale from the EU countries to Russia to sell them in the Northwest Federal District. A screenshot from a video provided by the Russian Federal Security Service. The image is a handout courtesy of a third party. Editorial use only. Archiving, commercial use and use in advertising are prohibited.27.04.2018#5485681
Pills confiscated by the Russian Federal Security Service during the arrest of the group involved in organizing illegal cross-border drugs and psychotropic substances trafficking channels on an especially large scale from the EU countries to Russia to sell them in the Northwest Federal District. A screenshot from a video provided by the Russian Federal Security Service. The image is a handout courtesy of a third party. Editorial use only. Archiving, commercial use and use in advertising are prohibited.27.04.2018#5485682